Neogen Corporation - Asset Resilience Ratio
Neogen Corporation (NEOG) has an Asset Resilience Ratio of 0.00% as of May 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Neogen Corporation to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2025)
This chart shows how Neogen Corporation's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see NEOG total assets.
Liquid Assets Composition Over Time
This chart breaks down Neogen Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Neogen Corporation debt and liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Neogen Corporation maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Neogen Corporation Industry Peers by Asset Resilience Ratio
Compare Neogen Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
LENSAR Inc
NASDAQ:LNSR |
Medical Devices | 0.00% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 14.18% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
Annual Asset Resilience Ratio for Neogen Corporation (1999–2025)
The table below shows the annual Asset Resilience Ratio data for Neogen Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-05-31 | 0.00% | $0.00 | $3.44 Billion | -- |
| 2024-05-31 | 0.01% | $325.00K | $4.55 Billion | -1.80pp |
| 2023-05-31 | 1.81% | $82.33 Million | $4.55 Billion | -32.09pp |
| 2022-05-31 | 33.90% | $336.58 Million | $992.93 Million | +0.70pp |
| 2021-05-31 | 33.20% | $305.49 Million | $920.19 Million | -1.60pp |
| 2020-05-31 | 34.80% | $277.40 Million | $797.18 Million | +2.34pp |
| 2019-05-31 | 32.46% | $225.84 Million | $695.74 Million | +11.79pp |
| 2018-05-31 | 20.67% | $127.74 Million | $618.01 Million | +8.17pp |
| 2017-05-31 | 12.50% | $66.07 Million | $528.41 Million | +0.87pp |
| 2016-05-31 | 11.63% | $52.54 Million | $451.71 Million | -0.63pp |
| 2015-05-31 | 12.27% | $48.10 Million | $392.18 Million | +1.89pp |
| 2014-05-31 | 10.37% | $35.82 Million | $345.30 Million | -1.84pp |
| 2013-05-31 | 12.22% | $35.34 Million | $289.25 Million | +4.43pp |
| 2012-05-31 | 7.79% | $19.60 Million | $251.60 Million | -1.42pp |
| 2011-05-31 | 9.21% | $20.24 Million | $219.66 Million | +9.04pp |
| 2006-05-31 | 0.17% | $150.00K | $88.29 Million | -0.38pp |
| 2004-05-31 | 0.55% | $331.00K | $59.98 Million | -15.76pp |
| 2003-05-31 | 16.31% | $7.84 Million | $48.04 Million | +5.43pp |
| 2002-05-31 | 10.88% | $4.34 Million | $39.90 Million | -8.30pp |
| 2001-05-31 | 19.18% | $6.33 Million | $33.02 Million | -9.51pp |
| 2000-05-31 | 28.69% | $8.47 Million | $29.53 Million | -8.09pp |
| 1999-05-31 | 36.78% | $9.60 Million | $26.10 Million | -- |
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage … Read more